New data presented by Andy Tien, MD, MS, of Kaiser Permanente Medical Center in Los Angeles points to an increased risk of dying from COVID-19 in liver transplant patients.
Barbara Andrews, NP, of the University of California San Diego Health System, illustrated the crucial steps to ensuring correct diagnosis of liver lesions and the challenges in doing so.
SSAT President Mark P. Callery, MD, highlighted presentations that reflect the wide range of recent clinical innovations and successful outcomes of surgery for the GI tract, liver and pancreas.
Researchers saw a significant increase in the number of alcohol-related gastrointestinal and liver disease consults during the COVID-19 pandemic.
During his state-of-the-art lecture, Dr. Roberts will review the emerging local and systemic therapies for HCC and describe the key changes needed to cement progress in the field.
Join Dr. Garcia-Tsao’s state-of-the-art lecture on complications of cirrhosis and strategies for reducing portal pressure on May 21.
Dr. Friedman’s state-of-the-art lecture will introduce established and new principles of fibrosis pathogenesis in liver.
In her state-of-the-art lecture, Dr. Rinella will discuss recent clinical trial results in NASH and contextualize their findings.
After attending the session “Applications and Pitfalls of Lumen Apposing Endoscopic Stents in EDGE Procedures,” participants will understand the benefits, complications and long-term risks of these novel approaches.
Dr. Callery’s presidential address will emphasize partnership, collaboration and unity across DDW as essential to future success.
